connect
structur
character
xray
crystallographi
nuclear
magnet
reson
nmr
among
diubq
chain
adopt
close
compact
conform
two
ubq
protein
interact
diubq
chain
adopt
open
flexibl
conform
two
ubq
molecul
interact
beyond
isopeptid
bond
connect
highli
flexibl
open
conform
diubq
chain
provid
even
altern
bind
mode
protein
partner
polyubq
chain
abund
homotyp
polyubq
speci
act
label
protein
degrad
up
proteasom
inhibit
caus
fast
increas
protein
mutat
ly
residu
yeast
ubq
show
essenti
residu
among
eight
lysmet
anchor
point
ubq
ubq
chain
length
vari
monoubq
polyubq
anchor
point
enzym
involv
multistep
process
includ
ubq
activ
conjug
transfer
protein
substrat
chain
trim
combin
ubq
code
easili
match
experiment
observ
thousand
ubqlabel
protein
substrat
multipl
site
ensur
exquisit
specif
ubqupsdepend
regul
function
reconduc
ubiquitin
protein
ubq
machineri
select
anchor
point
ubq
chain
length
natur
specif
substrat
ubiquitin
deubiquitin
dynam
cellular
environ
ubq
activ
two
ubqactiv
enzym
format
high
energi
cysubq
thioester
bond
enzym
reliev
ubq
cargo
ubqconjug
enzym
transthiol
reaction
enzym
contain
highli
conserv
aa
ubqconjug
ubc
catalyt
fold
act
scaffold
enzym
ubq
ligas
activ
ubq
ligas
receiv
ubq
enzym
transfer
substrat
three
main
mechan
realli
interest
new
gene
ring
ligas
directli
transfer
ubq
complex
ring
protein
substrat
homolog
carboxyl
terminu
hect
ligas
first
bind
ubq
onto
cy
residu
hect
domain
releas
enzym
bind
protein
substrat
transfer
ubq
ringinbetweenr
rbr
ligas
act
ringhect
hybrid
mechan
monoand
polyubq
chain
disassembl
class
isopeptidespecif
deubiquitin
enzym
dub
essenti
ensur
proper
process
ubiquitin
protein
final
proteasom
complex
protein
degrad
termin
ubqtag
protein
eukaryot
made
barrelshap
catalyt
core
particl
cp
compos
subunit
structur
arrang
four
stack
seven
member
ring
two
regulatori
particl
rp
compos
subunit
subunit
lid
subunit
base
structur
ubq
activationconjugationligationtrim
cycl
extens
describ
biologyori
companion
book
dub
enzym
may
consid
suitabl
target
restor
up
activ
impair
cellular
environ
proteasom
activ
may
also
target
direct
effect
up
ndd
tauopathi
requir
potentiationrestor
cellular
mechan
lead
elimin
misfoldedaggreg
protein
up
inhibit
may
appear
lead
opposit
directiondecreas
upsmedi
elimin
tau
misfold
protein
certain
enzym
up
system
though
contribut
elimin
protein
hinder
rescuingrefold
misfold
protein
inhibit
thu
benefici
particular
carboxyterminu
protein
chip
ubq
ligas
due
ubox
domain
cterminu
cochaperon
due
three
tandem
tetratricopeptid
tpr
domain
nterminu
chip
key
player
cellular
manag
misfold
protein
role
tauubiquitin
enzym
known
decad
ubiquitinspecif
proteas
ubqtrim
proteasomebound
dub
free
recycl
ubq
substrat
protein
degrad
up
role
physiolog
patholog
event
cn
well
known
next
two
section
describ
small
molecul
modul
act
select
target
role
chip
cellular
manag
misfold
protein
due
three
ntermin
tprchaperonebind
domain
repeat
ctermin
uboxubqbind
domain
modul
whole
set
chip
function
would
like
impact
mani
physiolog
process
specif
may
target
chaperonemedi
chipmisfold
protein
interact
tpr
domain
aim
regul
targetsubstr
protein
clearanc
ie
increas
ndd
specif
may
also
obtain
target
enzym
interact
ubox
domain
aim
regul
clearanc
misfold
protein
specif
coupl
ubiquitin
particular
targetsubstr
protein
ndd
often
depend
proaggreg
misfold
protein
chip
may
contribut
refold
complex
either
neurotox
protein
oligom
exceed
refold
capac
neuron
pqc
machineri
impair
chip
may
promot
aggreg
protein
oligom
insolubl
less
toxic
aggreg
clear
via
autophagi
see
autophagi
aggrephagi
chapter
biologyori
companion
book
either
inhibit
chip
overexpress
increas
amount
protein
clearancedirect
complex
inhibitor
describ
chapter
small
molecul
capabl
promot
chip
induct
cell
unknown
protein
regul
chip
capabl
orient
fate
misfold
protein
well
known
member
athanogen
cochaperon
famili
bag
may
mediat
dock
chipchaperonetarget
protein
complex
proteasom
facilit
proteasom
degrad
may
suppress
chipmedi
ubiquitin
degrad
target
protein
abrog
interact
may
promot
autophag
clearanc
complex
chip
age
andor
protein
aggregaterich
tissu
final
may
inhibit
chipmedi
ubiquitin
degrad
target
protein
unclarifi
molecular
mechan
protein
cochaperon
caus
conform
chang
chipchaperon
complex
prevent
ubiquitin
client
protein
protein
inhibit
chipmedi
ubiquitin
proteasom
degrad
ca
depend
manner
stimul
effect
inhibitionprevent
chip
neg
regul
cochaperon
would
desir
ndd
unfortun
limit
structur
inform
chipcontain
chaperon
complex
avail
drive
ration
drug
design
project
exampl
select
modul
chiptarget
protein
complex
presenc
hsp
chaperon
scarc
small
molecul
act
tprmediat
interact
chip
chaperon
cochaperon
misfold
protein
uncommon
select
best
question
thioflavin
b
figur
see
also
b
figur
section
mixtur
benzothiazolylammonium
salt
show
submm
potenc
prevent
interact
interact
could
modul
b
although
cellular
activ
thioflavin
could
due
mechan
sulfonamid
pifithrinm
pe
see
also
figur
section
show
multipl
action
machineri
complex
chip
jdomain
protein
affect
pe
multipl
potent
anticanc
effect
may
caus
part
tripl
bond
chemic
reactiv
probabl
entir
amen
chaperon
network
natur
occur
gambog
acid
ga
caus
upsdepend
degrad
mutant
ga
decreas
interact
parallel
increas
level
ternari
upsori
complex
molecular
interact
yet
elucid
upsmedi
degrad
polyubq
mutant
via
select
chip
ubiquitin
may
gadriven
effect
share
misfold
protein
tricycl
phenothiazin
methylen
blue
mb
current
clinic
trial
ad
patient
tau
aggreg
inhibitor
neg
modul
polyq
protein
degrad
bind
subsequ
submm
inhibit
chipmedi
polyq
protein
ubiquitin
multitarget
activ
profil
discuss
detail
chapter
imidazolebas
apoptozol
figur
restor
defect
cellular
process
cystic
fibrosi
transmembran
conduct
regul
mutant
misfold
protein
involv
cystic
fibrosi
rescu
effect
submm
concentr
like
due
disrupt
tertiari
protein
complex
prevent
chipmedi
ubiquitin
degrad
small
molecul
modul
chaperoneindepend
ligasetarget
protein
complex
known
although
target
chipcontain
complex
indirectli
prove
druggabl
proteinprotein
interact
ppi
must
mention
two
ring
ligas
target
candid
clinic
evalu
tetrasubstitut
clinic
test
ppi
inhibitorsanticanc
agent
target
doubl
minut
ppi
ring
ligas
modul
upsmedi
degrad
compound
inhibit
ubiquitin
bicycl
thiadiazol
thiazolebas
monomer
respect
dimer
antagonist
inhibitor
apoptosi
protein
iap
figur
clinic
trial
anticanc
agent
structur
inspir
ntermin
avpi
sequenc
second
mitochondriaderiv
activ
caspasedirect
inhibitor
apoptosisbind
protein
low
pi
smacdiablo
endogen
ligand
iap
act
ppi
inhibitorssmac
mimeticsiap
antagonist
prevent
interact
iap
protein
caspas
also
bind
ring
domaincontain
cellular
iap
ciap
activ
ligas
activ
induc
autoubiquitin
rapid
proteasom
degrad
ligasecontain
complex
target
small
molecul
earlier
develop
stage
molecul
often
discov
high
throughput
screen
ht
campaign
assay
format
detect
variat
ligas
activ
sphase
kinaseassoci
proteinskpcullinfboxcontain
scf
largest
multiprotein
ring
ligas
famili
diamino
compound
figur
identifi
ht
campaign
target
inhibitor
ubiquitin
enhanc
up
degrad
associ
poor
prognosi
varieti
tumor
scf
ligas
degrad
compound
moder
increas
level
cell
exclus
scf
ligas
complex
probabl
inhibit
bind
anoth
complex
member
inhibitor
scf
ligas
activ
stem
structurebas
virtual
screen
compound
data
set
ternari
complex
alkyliden
thiazolidin
compound
reduc
ubiquitin
vitro
low
mm
concentr
increas
level
decreas
scf
mediat
degrad
melanoma
cell
diacid
identifi
inhibitor
scf
ht
campaign
member
collect
bind
domain
fbox
protein
cell
divis
control
protein
shown
xray
structur
complex
conform
chang
induc
alloster
inhibit
substrat
recognit
ubiquitin
scf
although
domain
share
fbox
protein
sever
scf
ring
ligas
appear
select
scf
activ
cellular
assay
two
carboxyl
prevent
cellular
permeabl
respect
benzodiazepindionebas
triazinebas
identifi
compound
collect
ht
campaign
target
autoubiquitin
synoviolin
ring
ligas
highli
express
synoviocyt
patient
suffer
rheumatoid
arthriti
compound
show
moder
mm
potenc
synoviolin
autoubiquitin
show
complet
specif
vs
three
ring
ligas
nonselect
compound
show
vivo
activ
collageneinduc
arthriti
model
tetracycl
identifi
phenotypebas
ht
look
small
molecul
enhanc
therapeut
effect
rapamycin
see
also
autophagi
chapter
biologyori
companion
book
inhibit
ring
ligas
scf
bind
fbox
motif
protein
prevent
interact
skc
core
protein
select
complet
inact
scf
final
bisimid
thalidomid
figur
bind
cereblon
crbn
compon
ring
ligas
complex
inhibit
interact
damag
dna
bind
protein
cullin
inhibit
autoubiquitin
cell
vivo
zebrafish
chicken
model
teratogen
thalidomid
least
partial
due
crbn
bind
ligas
inhibit
interact
chip
conjug
enzym
extens
studi
xray
structur
murin
chip
complex
enzym
zebrafish
chip
avail
conform
dynam
human
complex
studi
amid
hydrogen
exchang
mass
spectrometri
hxm
highlight
differ
suggest
complex
protein
ubiquitin
chaperon
interact
select
modul
systemat
studi
identifi
subset
enzym
bind
chip
common
serproala
motif
promot
target
protein
ubiquitin
via
activ
conjug
ubiquitin
target
protein
depend
conjug
enzym
term
point
attach
other
ubq
chain
length
exampl
preferenti
catalyz
monoubiquitin
target
protein
ly
residu
seem
polyubqintroduc
complex
specif
final
tertiari
complex
contain
either
breast
cancer
type
ring
domain
protein
bard
ligas
conjug
enzym
studi
nmr
studi
provid
valuabl
inform
role
ringubox
ligas
chip
facilit
ubq
transfer
promot
alloster
activ
complex
wealth
structur
inform
yet
translat
small
molecul
regulatorsmodul
chip
binari
chip
tertiari
complex
function
member
largest
uspubiquitinspecif
proteas
subfamili
contain
character
famili
member
sever
usp
enzym
valid
target
variou
diseas
cn
diseas
particular
usp
dub
inhibitor
vari
degre
interclass
select
known
ubq
analog
capabl
specif
irrevers
inactiv
thiol
proteas
function
usp
includ
ubq
aldehyd
ubq
vinyl
sulfon
use
probe
identifi
character
cystein
proteas
dub
peptid
natur
aspecif
hinder
use
either
structur
model
drug
discoveri
effort
aspecif
usp
inhibitor
includ
electrophil
dienon
result
comput
pharmacophor
search
nation
cancer
institut
nci
chemic
databas
curcumin
figur
shikoccin
cytotox
compound
whose
cellular
activ
least
partial
due
dub
inhibit
potent
repres
among
electrophil
prostaglandin
whose
activ
uch
dub
also
report
curcumin
cover
detail
antiaggreg
properti
amyloidogen
peptid
chapter
biologyori
companion
book
dienon
nsc
show
similar
aspecif
dub
inhibit
bisisothiocyan
aspecif
dub
inhibitor
isol
pandubtarget
ht
campaign
caus
protein
aggreg
neuron
cell
stabil
microtubul
mt
possibl
effect
tau
tricycl
dinitril
result
structur
optim
hit
ht
campaign
target
usp
famili
member
stabil
induc
apoptosi
cancer
cell
inhibit
enzym
inhibit
least
five
usp
uch
dub
famili
member
compound
report
select
inhibitor
structur
similar
induc
suspect
limit
select
dub
gold
complex
potent
inhibit
dub
endow
cytotox
activ
cyanoamid
member
synthet
tyrphostinlik
librari
activ
cellbas
screen
target
toward
janusactiv
kinas
jak
signal
transduc
activ
transcript
stat
pathway
partial
select
cell
permeabl
usp
inhibitor
activ
show
proapotot
effect
upregul
downregul
myeloid
cell
leukemia
sequenc
level
promot
aggresom
format
cancer
cell
cellular
effect
due
inhibit
unknown
dub
respons
deubiquitin
also
enhanc
bacteri
kill
via
local
induc
nitric
oxid
synthas
ino
macrophag
phagosom
show
antivir
activ
induct
unfold
protein
respons
upr
alkylidenpyrazolidindion
origin
report
select
irrevers
ubqactiv
enzym
inhibit
sever
dub
even
unrel
cyscontain
enzym
displac
nitro
function
cy
residu
betulin
acid
figur
show
multipl
dubinhibit
activ
cytotox
prolifer
cancer
cell
similar
effect
normal
cell
may
due
gener
increas
dub
level
prolifer
vs
nonprolifer
cell
partial
select
inhibit
betulin
acid
subset
dub
highli
overexpressedmuch
activ
cancer
cell
chalconebas
librari
contain
cytotox
upsinhibit
repres
member
figur
partial
select
dub
inhibitor
inhibit
overal
dub
activ
cervic
cancer
hela
cell
mm
among
dub
inhibit
affect
analog
induc
polyubq
accumul
deplet
free
ubq
pool
promot
apoptosi
cancer
cell
nontox
normal
cell
antipsychot
phthalimidebas
pimozid
select
alloster
low
mm
inhibitor
dub
enzym
associ
factor
complex
pimozid
weakli
inhibit
select
wide
set
cystein
proteas
restor
cisplatin
sensit
cisplatinresist
small
lung
cancer
cell
phenotyp
screen
aim
toward
autophagi
inhibitor
identifi
specif
potent
autophagi
select
nm
inhibitor
dub
act
key
compon
autophagyregul
kinas
vacuolar
protein
sort
complex
see
also
autophagi
chapter
biologyori
companion
book
convers
complex
regul
level
autophagi
inhibit
increas
level
may
repres
novel
anticanc
approach
thiophenebas
dub
inhibitor
low
mm
potenc
identifi
pandubtarget
ht
campaign
increas
ubiquitin
degrad
lead
cytotox
cancer
cell
restor
sensit
bortezomibresist
cancer
cell
show
synergist
effect
combin
proteasom
histon
deacetylas
hdac
inhibitor
structur
relat
analog
potent
cellular
assay
caus
increas
level
induct
aminotetrahydroacridin
cell
permeabl
select
moder
potent
inhibitor
identifi
ht
campaign
regul
subsequ
cytotox
observ
human
colon
carcinoma
cancer
cell
naphthylamid
nm
noncoval
inhibitor
papainlik
proteas
plpro
sever
acut
respiratori
syndrom
sar
caus
coronaviru
plpro
act
dub
antivir
properti
result
structur
optim
ht
hit
stem
inhibit
deubiquitinas
activ
plpro
inhibit
human
dub
specif
explain
xray
structur
complex
two
small
molecul
inhibitor
known
electrophil
dienon
proapoptot
compound
identifi
ht
campaign
nci
chemic
collect
induc
caspasedepend
apoptosi
increas
level
polyubq
protein
dub
inhibit
select
inhibit
moder
potenc
two
structur
unrel
proteasom
dub
probabl
common
associ
proteasom
show
vivo
potenc
anim
model
leukemia
colon
lung
breast
carcinoma
pyrrolebas
figur
select
low
mm
inhibitor
enhanc
vitro
ubqtransact
responsetar
dna
bind
protein
ubqtau
level
increas
upsmedi
proteolysi
murin
embryon
fibroblast
mef
show
antivir
properti
dengu
viru
like
up
enhanc
tauand
role
consequ
put
therapeut
effect
question
compensatori
increas
activ
observ
elderli
cell
addit
basic
studi
potent
select
compound
need
elucid
potenti
clean
mix
inhibitor
neurodegener
even
small
select
profil
chang
may
induc
major
alter
cellular
effect
exampl
regul
activ
interleukin
il
releas
inflamm
model
clean
inhibitor
inact
model
exist
addit
unknown
dub
target
rule
import
cellperm
dub
inhibitor
fine
tune
polydub
pharmacolog
evid
avail
inform
regard
structur
dub
particular
crystal
structur
kda
catalyt
domain
isol
complex
ubq
aldehyd
assist
ration
design
synthesi
inhibitor
vari
select
profil
chapter
deal
small
molecul
modul
neuropatholog
alter
caus
protein
misfold
aggreg
gener
tau
andor
tauconnect
event
particular
potenti
therapeut
mechan
examin
detail
biologyori
companion
book
two
target
arbitrarili
chosen
thirtyeight
scaffold
shown
figur
act
select
target
describ
detail
chapter
briefli
summar
tabl
chemic
core
scaffoldcompound
structur
defin
molecular
target
mention
develop
laboratori
either
public
privat
list
develop
statusaccord
publicli
avail
informationi
final
provid
